Belpointe Asset Management LLC Eli Lilly & CO Transaction History

Belpointe Asset Management LLC

$1.28 Billion
Q2 2024

A detailed history of Belpointe Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Belpointe Asset Management LLC holds 5,730 shares of LLY stock, worth $5.11 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

5,730

Previous 5,250 9.14%

Holding current value

$5.11 Million

Previous $4.08 Million 27.01%

% of portfolio

0.4%

Previous 0.33%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$724.87 - $909.04 $347,937 - $436,339	480 Added 9.14%	5,730 $5.19 Million
Q1 2024 May 08, 2024	BUY	$592.2 - $792.28 $44,415 - $59,421	75 Added 1.45%	5,250 $4.08 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $92,958 - $109,586	177 Added 3.54%	5,175 $3.02 Million
Q3 2023 Nov 15, 2023	SELL	$434.7 - $599.3 $163,881 - $225,936	-377 Reduced 7.01%	4,998 $2.68 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $1.74 Million - $2.32 Million	-4,952 Reduced 47.95%	5,375 $2.52 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $125,805 - $147,752	-405 Reduced 3.77%	10,327 $3.55 Million
Q4 2022 Feb 08, 2023	BUY	$321.55 - $374.67 $112,542 - $131,134	350 Added 3.37%	10,732 $3.93 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $1.19 Million - $1.35 Million	4,001 Added 62.7%	10,382 $3.36 Million
Q2 2022 Aug 02, 2022	SELL	$278.73 - $327.27 $405,552 - $476,177	-1,455 Reduced 18.57%	6,381 $2.07 Million
Q1 2022 Apr 28, 2022	BUY	$234.69 - $291.66 $83,784 - $104,122	357 Added 4.77%	7,836 $2.25 Million
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $71,502 - $88,734	318 Added 4.44%	7,479 $2.07 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $241,100 - $296,708	1,088 Added 17.92%	7,161 $1.65 Million
Q2 2021 Aug 09, 2021	BUY	$180.55 - $233.54 $116,454 - $150,633	645 Added 11.88%	6,073 $1.39 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $157,747 - $204,211	960 Added 21.49%	5,428 $977,000
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $70,187 - $92,874	538 Added 13.69%	4,468 $756,000
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $378,563 - $437,877	2,589 Added 81.44%	5,768 $801,000
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $268,752 - $310,860	-1,838 Reduced 31.87%	3,930 $581,000
Q2 2020 Jul 20, 2020	SELL	$136.42 - $164.18 $353,191 - $425,062	-2,589 Reduced 44.89%	3,179 $522,000
Q1 2020 Jul 20, 2020	SELL	$119.05 - $147.35 $274,291 - $339,494	-2,304 Reduced 28.54%	5,768 $801,000
Q4 2019 Feb 18, 2020	BUY	$106.92 - $132.43 $610,299 - $755,910	5,708 Added 241.46%	8,072 $1.06 Million
Q3 2019 Jan 16, 2020	BUY	$106.79 - $116.16 $13,028 - $14,171	122 Added 5.44%	2,364 $264,000
Q2 2019 Nov 22, 2019	SELL	$110.79 - $129.32 $60,823 - $70,996	-549 Reduced 19.67%	2,242 $0
Q1 2019 Jun 11, 2019	SELL	$111.31 - $131.02 $257,905 - $303,573	-2,317 Reduced 45.36%	2,791 $362,000
Q4 2018 Mar 06, 2019	SELL	$105.9 - $118.64 $300,967 - $337,174	-2,842 Reduced 35.75%	5,108 $591,000
Q3 2018 Nov 23, 2018	BUY	$85.86 - $107.31 $682,587 - $853,114	7,950 New	7,950 $853,000
Q4 2017 Feb 15, 2018	SELL	$81.94 - $87.89 $499,424 - $535,689	-6,095 Closed	0 $0
Q3 2017 Nov 16, 2017	BUY	$77.07 - $85.54 $469,741 - $521,366	6,095	6,095 $521,000

Others Institutions Holding LLY

# of Institutions

3,869

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $847B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Account

Belpointe Asset Management LLC Eli Lilly & CO Transaction History